S100 Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosis
S100 Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosis